Discover the news of an experienced Contract Research Organization specialized in Biostatistics and eClinical services to optimize your clinical trials.
Dr. Everardo Saad, Medical Director of IDDI contributed to an article on Personalized Medicine published in the June issue of PharmaVOICE, both digital and printed. “Advances in big-data analytics are increasingly being employed to extract targeted information with the potential […]
May 25, 2021
In addition to pharmaceutical and biopharmaceutical sponsors outsourcing clinical trials to Contract Research Organizations (CROs) to gain flexibility and speed the drug development process, key factors impacting market trends include technology and digital modernization of clinical trials, advanced therapies and […]
Read article on trial design and sample sizes for early trials Written by Elisabeth Coart and Everardo D. Saad, Consulting Services & Research, IDDI ABSTRACT Introduction: Precision medicine is impacting clinical practice and drug development in oncology, promoting notable changes […]
Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents are used based on the expression of predictive biomarkers. Even though late-phase trials of precision oncology are undergoing transformations, we […]
June 2, 2021 — June 3, 2021
Join IDDI at PCMG 2021 Erik Falvey, Sr Director BD Europe IDDI will be there virtually! Want to set up a meeting? Contact him directly at: erik.falvey@iddi.com or connect with him on the PCMG CONNECT online meeting! Topics of the PCMG […]
April 20, 2021 — April 23, 2021
Join IDDI at NLSDays 2021! Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Register here ! Erik Falvey, Sr Director BD Europe will be there virtually! Want to set up a meeting? […]
June 18, 2021
Listen to Marc Buyse, ScD speaker at the DIA Global Meeting 2021 His talk is entitled ‘Randomized Controlled Trials (RCTs): Lessons from COVID-19′ and is part of the session: ‘Building from Opportunities from a Pandemic to influence the future of Clinical […]
June 28, 2021
TOPICS OF the PRECISION MEDICINE AND HTA ASSESSMENT WEBINAR Precision medicine aims to tailor disease prevention, diagnosis and treatment to the individual patient, based on their individual features. Health Technology Assessment (HTA) is an instrumental part of the process in […]
September 21, 2021 — September 23, 2021
Rockville, MD, USA
Marc Buyse, ScD, plenary panel session speaker at The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop. The plenary panel discussion topic will be “Statistics in the Changing Product-Development Environment Accelerated by the Pandemic”. The theme of this year’s workshop is “Statistical […]
May 17, 2021 — May 20, 2021
IDDI presenting two sessions at theClinical Trials Annual Meeting May 18 – 5pm: Marc Buyse, ScD will give a talk on “RECENT DEVELOPMENTS IN QUANTITATIVE BENEFIT-RISK ASSESSMENT IN CLINICAL TRIALS” In this session Dr. Buyse focused on the recent development of […]